Test Code LABDSOTC Drug Screen, Prescription/Over the Counter, Random, Urine
Additional Codes
Test Name in EPIC | EPIC Test Code | Mnemonic | Mayo Test ID |
---|---|---|---|
DRUG SC PRESCRIPT/OTC, U | LABDSOTC | PDSU | PDSU |
Reporting Name
Drug Screen, Prescription/OTC, UUseful For
Qualitative detection and identification of prescription or over-the-counter drugs frequently found in drug overdose or used with a suicidal intent
Providing, when possible, the identification of all drugs in the specimen
This test is not intended for use in employment-related testing.
This test is not intended for therapeutic compliance testing. The assay's limits of detection have been established for drugs at overdose levels, which are generally much higher than therapeutic concentrations.
This test is not useful for drugs of abuse or illicit drug testing, including benzodiazepines, opioids, barbiturates, cocaine, and amphetamine type stimulants.
Method Name
Gas Chromatography Mass Spectrometry (GC-MS)
Performing Laboratory
Mayo Clinic Laboratories in RochesterSpecimen Type
UrineOrdering Guidance
This test is not performed using chain of custody. For chain-of-custody testing, order PDSUX / Drug Screen, Prescription/Over the Counter, Chain of Custody, Random, Urine.
Specimen Required
Supplies: Sarstedt Aliquot Tube, 5 mL (T914)
Collection Container/Tube: Plastic urine container
Submission Container/Tube: Plastic vial
Specimen Volume: 5 mL
Collection Instructions:
1. Collect a random urine specimen.
2. No preservative. Specimens containing preservative may be canceled.
Specimen Minimum Volume
1.1 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Urine | Refrigerated (preferred) | 14 days | |
Frozen | 14 days | ||
Ambient | 3 hours |
Reject Due To
All specimens will be evaluated at Mayo Clinic Laboratories for test suitability.Special Instructions
Reference Values
Drugs detected are presumptive. Additional testing may be required to confirm the presence of any drugs detected.
Day(s) Performed
Monday through Friday
CPT Code Information
80307
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
PDSU | Drug Screen, Prescription/OTC, U | 12286-1 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
31260 | Drugs detected: | 12286-1 |
45529 | Suspect Drug | No LOINC Needed |
Test Classification
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.Clinical Information
This test looks for a broad spectrum of prescription and over-the-counter medications. It is designed to detect drugs that have toxic effects, as well as known antidotes or active therapies that a clinician can initiate to counteract the toxic effect. The test is intended to help physicians manage an apparent overdose or intoxicated patient or to determine if a specific set of symptoms might be due to the presence of drugs. This test is not appropriate for drugs of abuse or illicit drug testing, including benzodiazepines, opioids, barbiturates, cocaine, and amphetamine-type stimulants.
Drugs of toxic significance that are not detected by this test are digoxin, lithium, salicylate, and many drugs of abuse or illicit drugs, some benzodiazepines, and some opioids. For these drugs, see Mayo Clinic Laboratories' drug abuse surveys, drug screens, or individual tests.
For detection limits for drugs detected in this test see Prescription and Over-the-Counter Drug Screening List and Limits of Detection.
Interpretation
The drugs that are detected by this test are listed in Prescription and Over-the-Counter Drug Screening List and Limits of Detection.
A detailed discussion of each drug detected is beyond the scope of this text. Each report will indicate the drugs identified. If a clinical interpretation is required, contact Mayo Clinic Laboratories at 800-533-1710 and ask to speak to a toxicology consultant.
Cautions
No significant cautionary statements
Method Description
Screening is by gas chromatography mass spectroscopy.(Unpublished Mayo method)
Report Available
2 to 4 daysSpecimen Retention Time
2 weeksForms
If not ordering electronically, complete, print, and send a Therapeutics Test Request (T831) with the specimen.